These results indicate compromised Th-1 responses in IPF patients after BNT162b2 vaccination and possibly impaired protection in this group as reduced IFNγ secretion has been connected with attenuated humoral responses to mRNA COVID-19 vaccines (40). This evidence concerns the gene IFNG and COVID-19.